Mucositis: Difference between revisions
Ryantenold (talk | contribs) |
Ryantenold (talk | contribs) |
||
| Line 22: | Line 22: | ||
==Management== | ==Management== | ||
*Prevention with multi agent, combination oral care | |||
==Disposition== | ==Disposition== | ||
Revision as of 22:34, 6 January 2021
Background
- One of the most common side effects of cancer treatment with chemotherapy or radiation
- Occurs in almost all cases of head or neck radiation
- 20-80% of people who receive chemotherapy
Clinical features
- Erythema and ulcerations of the mucosal lining of the gastrointestinal tract
- Causes dysphagia, changes in taste, secondary infections, weight loss
- Oral mucositis is associated with increased inpatient hospitalization duration, bacteremia and higher 100‐day mortality.
- GI mucositis is associated with nausea, vomiting, bloating, diarrhea, intestinal cramping and anal pain.
Differential Diagnosis
- Oral candidiasis
- Herpes simplex virus infection
- Acute Graft-versus-Host disease
Evaluation
Workup
Diagnosis
Management
- Prevention with multi agent, combination oral care
Disposition
See Also
External Links
References
- ↑ Daugėlaitė G, Užkuraitytė K, Jagelavičienė E, Filipauskas A. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis. Medicina (Kaunas). 2019;55(2):25. Published 2019 Jan 22. doi:10.3390/medicina55020025